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Abstract. Most existing software systems lack explicit traceability links be-
tween artefacts, or if implemented, is often not leveraged to take advantage of
the information it can provide to a development or validation team.
Within the medical device domain, as in other safety critical domains, regu-
lation normally requires such systems are certified before entering service. This
involves submission of a safety case (a reasoned argument that the system is ac-
ceptably safe) to the regulator. A safety case should include evidence that the
organisation has established effective software development processes. At the
heart of such processes they must incorporate traceability.
However, numerous barriers such as a lack of awareness of traceability and a
lack of guidance as to how to implement traceability hamper the its effective
implementation. In this paper we address the lack of guidance on traceability
implementation by presenting our experience of developing and trialling a
traceability assessment model in two medical device organisations. We show
that the assessment model was successful in identifying strengths and weak-
nesses in both organisations implementation of traceability. Through experience
of trialling the model we propose an idea to improve it by automation, using the
Open Services for Lifecycle Collaboration (OSLC) initiative.
Keywords: Requirements traceability, Traceability assessment, Medical device,
Safety critical, Process assessment, Automation
1 Introduction
Traceability has been embraced by many software development
standards such as ISO/IEC 15504 [1] and CMMI [2] and its importance
is well recognised in the software engineering community. A report on
the needs and priorities for software research, commissioned by the
United Stated Department of Defense states that traceability is a prac-
tice that facilitates software assurance [3].
Traceability is the ability to follow the life of a requirement in both a
forward and backwards direction (i.e., from its origins through its de-
velopment and specification to its subsequent deployment and use, and
through all periods of on-going refinement and iteration in any of these
phases) [4]. In general, traceability is about understanding a design
right through from the origin of the requirement to its implementation,
test and maintenance. Traceability allows us to understand aspects such
as whether the customers’ requirements are being met, the specific re-
quirements that an artefact relates to, and the origins and motivation of
a requirement. Traceability helps ensure that ‘quality’ software is de-
veloped.
In addition to the many benefits offered by traceability, Industries are
often compelled to implement traceability practices by government
regulations [5]. For example Food and Drugs Administration (FDA)
state that traceability should verify that software requirements are
traceable to system requirements and to risk analysis results, a software
design implements all of the software requirements, and that all code is
linked to established specifications and established test procedures [6].
Similiarily the Federal Aviation Authority (FAA) require that a Low
Level Requirement (LLR) traces up to a High Level Requirement
(HLR) and that each requirement is fulfilled by the source code, that
each requirement is tested, that each line of source code is connected to
a requirement.
However despite its many benefits and regulatory requirements it
seems that ‘often the quality of traceability information is poor, or out-
of- date due to improper maintenance’ [7]. Reports from the field are
few and far between when it comes to traceability. Much research has
been conducted on traceability that references studies conducted more
than a decade ago. However, we know very little about the traceability
practice as it occurs in companies today [8], except for the fact that
many software development enterprises do not maintain traceability in
an appropriate way [9, 10]. In fact ‘most existing software systems lack
explicit traceability links between artefacts’ [11].
Numerous reasons have been identified for reluctance in implement-
ing traceability including cost, complexity, building a requirements
trace matrix (RTM) is time consuming, arduous and error prone [17],
stakeholders having differing perceptions as to the benefits of traceabil-
ity [12], developers may fear that traces could be used to monitor their
work [18], and difficulties with trace tools [19]. Finally almost no guid-
ance is available for practitioners to help them establish effective trace-
ability in their projects and as a result, practitioners are ill-informed as
to how best to accomplish this task [8, 20].
To assist medical device organisations in addressing the lack of
guidance on how to implement effective traceability, this paper presents
the development and validation of a traceability process assessment
model (PAM). We present our experience of developing and trialling a
traceability assessment model in two medical device organisations and
show that the assessment model was successful in identifying strengths
and weaknesses in both organisations implementation of traceability.
Through experience of trialling the model we propose an idea to im-
prove it by automation, using the Open Services for Lifecycle Collabo-
ration (OSLC) initiative
The remainder of this paper is structured as follows: Section 2 out-
lines current assessment models’ relationship to traceability and the
need to automate the assessment and maintenance of traceability. Sec-
tion 3 outlines current assessment of traceability in medical device
standards and guidelines and assessment models such as ISO 15504.
Section 4 outlines the methodology used to develop the PAM while
section 5 details the structure of the developed PAM. Section 6 presents
validation of the PAM by expert review and industry trial while Section
7 discusses how traceability assessment and maintenance could be au-
tomated using the Open Services for Lifecycle Collaboration (OSLC)
initiative. Finally section 8 concludes the paper.
2 Related Work
A literature review was conducted to determine what other traceabil-
ity assessment models were available in the general, safety critical or
medical device domains. This review returned only one model on
traceability compliance/ capability assessment called Med-Trace [12].
Med-trace is a lightweight traceability assessment method, completed
in 8 stages, whose goal is to assist medical device organizations to im-
prove their software development traceability process. The authors
completed assessments on two medical device companies and were
able to identify areas for improvement in each company’s traceability
process.
There are a number of process assessment models which provide
common frameworks for assessing software process capability. These
models include ISO 15504 SPICE , Automotive SPICE [13], SPICE 4
SPACE [14], and CMMI. These frameworks assess processes such as
software design process, software construction process, software testing
process etc. However the frameworks do not include a dedicated trace-
ability assessment process. The frameworks do include traceability as-
sessment but it is spread out across a lot of processes and sometimes
difficult to interpret e.g. base practice 4 of the software construction
process (Eng. 6) in SPICE states;
“Verify software units. Verify that each software unit satisfies its de-
sign requirements by executing the specified unit verification proce-
dures and document the results”.
Explicit traceability is not required in the above statement but it may
be implied. It is open to interpretation.
It is important to highlight that traceability has been considered as a
key issue by the agile community as well. Scott Ambler, one of the key
personalities of the agile movement, states in 1999 that “My experience
shows that a mature approach to requirements traceability is often a key
distinguisher between organizations that are successful at developing
software and those that aren’t. Choosing to succeed is often the most
difficult choice you’ll ever make—choosing to trace requirements on
your next software project is part of choosing to succeed.” [15]
The same Scott Ambler’s advice in 2013 [16]:
“Think very carefully before investing in a requirements traceability
matrix, or in full lifecycle traceability in general, where the traceability
information is manually maintained. When does maintaining traceabil-
ity information make sense?
 Automated tooling support exists
 Complex domains
 Large teams or geographically distributed teams
 Regulatory compliance”
While the above view reflects the reluctance in implementing traceabil-
ity as discussed in the introduction, it also shows its importance in the
case of the medical device domain being both complex and subject to
regulatory compliance requirements.
Considering all of the above discussion, the need for the automation of
assessing and maintaining traceability is imminent. It is this automation
to which the Open Services for Lifecycle Collaboration (OSLC) initia-
tive opens the way also as discussed in this paper.
3 Traceability Assessment
A Software process provides a framework for the key activities of
software development. Good management of the process should pro-
vide for a sustained orderly improvement of the process. Software pro-
cess assessment assist organizations in understanding the current state
of their software process by identifying strengths and weaknesses in
their process and thus providing focus on areas for improvement. In
addition to assessing their own process an organization can use soft-
ware process assessment to determine the state of a supplier’s process.
3.1 Traceability Requirements
To understand the requirements for traceability each of the following
standards were analysed and appropriate traceability requirements ex-
tracted:
 IEC 62304 - Medical device Software lifecycle processes [17]
 FDA – Guidance documents [6, 18, 19]
 ISO 13485 - Medical devices — Quality management systems
[20]
 ISO 14971 - Application of risk management to medical devices
[21]
While each of the above standards had different requirements for trace-
ability, all the requirements were easily categorised as a requirement
for the Software Development Lifecycle (SDLC), Risk Management or
Change Management process. The requirements for the three processes
are indicated in Figures 1, 2 and 3. As way of explanation of these fig-
ures, the double headed arrow in Figure 1 with the number 13 attached
indicates a requirement for bidirectional traceability between code and
unit test.
Fig. 1 SDLC and links between phases @Annex E of the Automotive SPICE®
PAM
Fig. 2 Risk Management Traceability Overview
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Fig. 3 Change Management Traceability Overview
The above figures thus indicate twenty five separate requirements for
traceability as per the medical device standards and guidelines. These
requirements along with the best practices for implementing traceability
formed the basis for the PAM. The best practices for implementing
traceability are the result of an extensive literature review which was
completed prior to developing the PAM [22].
4 Research Methodology
The traceability PAM is based on ISO 15504-2 [23] and developed in
line with the structure shown in Figure 2.
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Fig. 4. Traceability Process Assessment Model Approach
It was decided to base the traceability assessment model on ISO/IEC
15504 as this improvement and capability determination model was
derived from ISO/IEC 12207 [24] and since ANSI/AAMI/IEC
62304:2006 (Software lifecycle processes for medical device software)
is also derived from ISO/IEC 12207 it was determined that there was
good synergy between ANSI/AAMI/IEC 62304:2006 and ISO/IEC
15504. Additionally, 15504 is used extensively in other safety critical
industries such as the automotive industry (Automotive SPICE), space
industry (SPICE 4 SPACE) and the medical device industry (Medi
SPICE).
The first stage was to develop a traceability PRM. The PRM was de-
veloped using the requirements from traceability (taken from the medi-
cal device standards and guidelines), traceability best practices (the re-
sult of an extensive literature review), and ISO 15504-2 section 6.2
which sets out the requirements for a Process Reference Model. While
ISO 15504-2 details the minimum requirements that a PRM and a PAM
should meet, it provides no guidance on how to develop the models i.e.
it does not tell you how to transform requirements into a PRM or PAM.
To address this issue, this study based the development of the PAM on
the Tudor IT Service Management Process Assessment (TIPA) trans-
formation process [25] which is a nine step process that complies with
the requirements for PRMs and PAMs as expressed in ISO/IEC 15504-
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2. The purpose of technical report ISO/IEC TR 24774:2010 [26] is to
encourage uniformity in the description of processes. Uniform descrip-
tion of processes across process reference models allows the combina-
tion of processes from different reference models to ease the develop-
ment of new models and facilitates comparison of models.
Once the PRM was developed the measurement framework and
PAM requirements as detailed in ISO 15504-2 were added to the PRM
to form the PAM.
5 Structure of Traceability PAM
The traceability assessment framework, illustrated in Figure 2, con-
sists of 4 traceability processes which are Change Management (CM)
traceability, Risk Management (RM) traceability, Software Develop-
ment Lifecycle (SDLC) traceability, and Best Practice traceability.
Each of the processes contains: (i) Title; (ii) Purpose, which contains
the unique functional objectives of the process when performed in a
particular environment; (iii) Outcomes, which are a list of expected
positive results of the process performance; (iv) Base practices, whose
performance provides an indication of the extent of achievement of the
process purpose and process outcomes; and (v) Work Products (WPs)
are either used or produced (or both), when performing the process.
The CM traceability process: The purpose of this process is to en-
sure that traceability is adequately addressed throughout all stages of
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Fig. 5 Traceability Process Assessment Framework
the Change management/Problem resolution process by assessing the
requirements for traceability as depicted in Figure 3.
The RM traceability process: The purpose of this process is to en-
sure that traceability is adequately addressed throughout all stages of
the risk management process by assessing the requirements for tracea-
bility as depicted in Figure 2.
The SDLC traceability process: The purpose of the SDLC Tracea-
bility Process is to ensure that traceability is adequately addressed
throughout all stages of the SDLC process by assessing the require-
ments for traceability as depicted in Figure 1
Traceability best practice process: The purpose of the Traceability
Best Practices process is to ensure that traceability best practices are
established when implementing traceability through the SDLC and the
supporting processes of risk management and change management.
This is achieved by assessing if a company policy and a standard oper-
ating procedure for traceability have been developed, the resources re-
quired for successful traceability implementation are made available,
and the appropriate techniques for successful implementation are de-
ployed.
6 Validation of PAM
The PAM has been validated initially by expert review and then by
trial in two medical device organisations. This section provides an
overview of the validation methodology and findings.
6.1 Validation by Expert Review
An initial validation of the traceability PAM has been conducted by
four experts who were chosen based on the following criteria; their ex-
pertise in: a) ISO/IEC 15504; b) medical device standards; c) require-
ments traceability; and d) medical device software development.
Details of the methodology used for the validation and the findings
which resulted from the validation have previously been published
[27]. A summary of the changes made to the PAM as a result of 25
comments made during the expert review now follows.
Change management process:
 Amended to include traceability of problem reports to change
requests.
 Add note indicating that bidirectional traceability is good
practice, even though it is not a requirement of IEC 62304
Traceability best practices process:
 Amended so that it will include reference to source documents.
As these documents are academic papers the references will be
included in an appendix
 Outcome 1 of the Traceability best practice process will be
changed from “a company policy on traceability and proce-
dures for its implementation are established” to “Establish a
plan for establishing traceability in the organisation/project”.
Risk Management traceability process:
 Note added indicating that bidirectional traceability is good
practice, even though it is not a requirement of IEC 62304 or
ISO 14971
 Outcome 7 to have following note attached: ‘IEC 62304 re-
quires that risk control measure implemented in software be
included in the software requirements specification’.
SDLC traceability process
 A note is added to Outcome 7 stating; ‘Where software re-
quirements cannot be addressed in software design (e.g. non-
functional requirements, attributes etc.), traceability between
software requirements and source code should be directly es-
tablished’.
 Amend Outcome 5 of the SDLC traceability to state that this
PAM only requires those system requirements that are imple-
mented in software to be traced. Also add note to Outcome 5
stating; if the system is a software only system, then outcomes
1, 2, 3 and 4 can be removed and Outcome 5 can be replaced
with “Traceability is provided between software requirements
and their source”.
6.2 Validation by Industry Trial
Two organisations were selected for trial of the PAM based on their
suitability and accessibility.
Organisation A are a small medical device software company based
in Ireland with a total of ten employees which include one programmer,
one software tester and one quality assurance person. The company has
been in existence since 2002. Their device has a software safety classi-
fication of B, meaning non-serious injury is possible.
Organisation B is a small Product Development & Design Engineer-
ing company focused on the Medical Device and Life Science market
and is based in Ireland. The company, which was formed in 2007, em-
ploy 14 individuals with skills in mechanical, hardware and software
engineering. The company are a third party supplier of software to
medical device companies and have recently been accredited with IEC
62304 certification.
To perform the assessment an eight stage process [28] was adopted.
It is determined that this process will allow for a comprehensive as-
sessment of an organisations traceability compliance without being too
onerous in terms of resources that the organisation need to provide.
The assessment results for both Organisations A and B are outlined
in Figures 3. Figure 3 is a UML diagram indicating how each organiza-
tion fulfils the medical device standards requirements for traceability
and is as a result of using the PAM to assess traceability through risk
management, change management and SDLC process. The dashed links
in Figure 3 indicate the links that Organisation A are implementing
while the dashed lines ending in a filled circle indicate the links that
Organisation A are not implementing. Similarly the solid links indicate
the links that Organisation B are implementing while the solid lines
ending in a filled circle indicate the links that Organisation B are not
implementing.
The results of the assessment indicate that while both organisations
are fulfilling many of the medical device requirements for traceability
they are both weak in the following areas:
 Tracing from hazardous situation to software item to software
cause. This is a particular requirement from IEC 62304.
 Tracing between software requirements and their initial source
 Tracing down to the code level
In following discussion with the organisations, they maintained that
the reason for the missing links was that they were simply unaware that
they were required.
In addition to these finding the assessment results also report that both
organisations are only partially applying the best practices for imple-
menting traceability or else not at all as depicted in Table 1.
The columns F,L,P and N indicate full, largely, partially or No imple-
mentation of traceability best practices. So for example neither organi-
sation A or B had a company policy on traceability.
Table 1 Best Practice Implementation Findings
Traceability Best Practices F L P N
Do you have a documented company policy on tracea-
bility? If so, where is it documented?
A
B
Have you established a Traceability improvement
communication method? If so, what is it?
A
B
Do you have a Traceability Infomation Model? A
B
Do you have a documented Standard Operating Pro-
cedure for Traceability
A
B
Are resources required for traceability made available
e.g. Training, Education, Tools, Time?
A
B
Are appropriate techniques deployed for effective
implementation of traceability e.g. inventory of current
tools and practices, review of traceability information.
A B
Fig.6 Organisation A and B Implementation of Traceability Requirements
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6.3 Discussion
One goal of the assessment was that it would not be too onerous in
terms of resources that the organisation needs to provide. For both or-
ganisations total contact time between assessor and organisation was
approximately 4 hours. This equated to 1.0 hours for steps 1 and 2 of
the assessment method (Develop appraisal schedule and conduct over-
view briefing), 1.5 hours for step 4 (conduct interviews), 1.5 hours for
steps 6 and 7 (Deliver findings report and agree improvement plan).
Step 8 of the assessment method (Re-assess the SPI Path and Produce a
Final Report) is still to be completed as a 3 month implementation pe-
riod was agreed. It is envisaged that step 8 will require no more than
1.5 hours of contact. Steps 3 and 5 of the assessment method (analyse
software documentation and create findings report) were conducted off-
site in both assessments and so required no input from either organisa-
tion. Due to the limited hours required, both organisations felt the as-
sessment was not onerous and considered the assessment and its find-
ings and recommendations to be very relevant and valuable.
Another goal of the assessment was that it would allow for a compre-
hensive assessment of an organisations compliance with the require-
ments for traceability and its implementation of traceability best prac-
tices, and provide a pathway for improvement. The assessment findings
clearly uncovered a number of weaknesses within both organisations,
with Organisation A missing 7 required links and Organisation B miss-
ing 15 links. The assessment thus demonstrated the level of non-
compliance with the medical device standards requirements for tracea-
bility, within both organisations. Additionally the assessment demon-
strated that, within both organisations, the level of traceability best
practice implementation was extremely low. Although the PAM does
not assess the reasons for non-implementation of traceability require-
ments or best practices, through informal discussion it has emerged that
the main reason is that the organisations were simply unaware of the
missing requirements and best practices. As a result of the assessment
both organisations are now aware of best practices for implementing
traceability. Furthermore the recommendations for improvement have
not only provided both organisations with a pathway for improvement,
but also with goals which they feel are reasonable, achievable and mo-
tivational.
While the PAM has been successful in achieving its goals we feel that
the assessment of traceability could be further improved. Although the
assessment was not overly onerous for the organisations, it did require
a couple of visits to the organizations and did put some demand on their
resources. Additionally the assessment provides a snapshot of traceabil-
ity implementation at a single point in time and does not account for
artefacts dynamically changing during production and maintenance.
Changing artefacts necessitates the need for maintaining the traceabil-
ity. To address these issues we describe our vision to automate the as-
sessment and maintenance of traceability.
7 Vision to automate the assessment and maintenance of
traceability
As discussed earlier, there is imminent need for the automation of
traceability assessment and maintenance. Considering the clear defini-
tion cited in the introduction, traceability is the ability to establish links
(or traces) between source artefacts and target artefacts [2]. According
to the state of the art of web technology, we have today the means to
identify and to establish links between immense numbers of artifacts
which can even be seamlessly traced on the basis of these links.
Our vision is that the processes defined in the Traceability Process
Assessment Model of this paper could be executed using a system ac-
cessing all of the necessary artifacts which would be accessible on the
web (internet or intranet). By consequent, this system would ultimately
have full traceability assessment and also resulting traceability mainte-
nance capability.
Application Lifecycle Management (ALM) tool vendors are perfectly
aware of this need, and some of the tools [29] contain features support-
ing a given level of automation. However, current ALM tools have fol-
lowing inherent weaknesses:
 Traceability is basically restricted to the closed ALM system. APIs
are available for providing internal data, however, no standardized
open form of exchange was made possible before the below dis-
cussed OSLC initiative.
 Useful traceability reports can be generated, but they are static
while requirements and identified defects are very dynamically
changing artefacts, and may even originate from outside the ALM
system.
 Assessors and users may be easily confused by the complexity of
the set of widgets, such as buttons, text fields, tabs, and links which
are provided to access and edit all properties of resources at any
time.
 Assessors and users need to reach destinations such as web pages
and views by clicking many links and tabs whose understanding is
not essential for the assessment.
Open Services for Lifecycle Collaboration (OSLC) is the recently
formed cross-industry initiative aiming to define standards for compat-
ibility of software lifecycle tools. Its aim is to make it easy and practi-
cal to integrate software used for development, deployment, and moni-
toring applications. This aim seems to be too obvious and overly ambi-
tious at the same time. However, despite its relatively short history
starting in 2008, OSLC is the only potential approach to achieve these
aims at a universal level, and is already widely supported by industry.
The unprecedented potential of the OSLC approach is based on its
foundation on the architecture of the World Wide Web, which is un-
questionably proven to be powerful and scalable, and on the generally
accepted software engineering principle to always focus first on the
simplest possible things that will work.
The elementary concepts and rules are defined in the OSLC Core
Specification which sets out the common features that every OSLC
Service is expected to support using the terminology and generally ac-
cepted approaches of the World Wide Web Consortium (W3C). One of
the key approaches is Linked Data being the primary technology lead-
ing to the Semantic Web which is defined by W3C as providing a
common framework that allows data to be shared and reused across
application, enterprise, and community boundaries.
The OSLC Core Specification is actually the core on which all
lifecycle element (domain) specifications must be built upon. Examples
of already defined OSLC Specifications include:
 Architecture Management
 Asset Management
 Automation
 Change Management
 Quality Management
 Requirements Management
We have seen that the Change Management Specification is highly
relevant to the traceability process assessment experiences discussed in
this paper. As OSLC has become part of the OASIS Open Standards
Network, the Change Management Specification is being further devel-
oped by the OASIS OSLC Lifecycle Integration for Change and Con-
figuration Management (OSLC CCM) Technical Committee to be ap-
proved as a full OASIS standard. OASIS is an international nonprofit
consortium with wide impact that brings companies, governments, aca-
demia, and individuals together to solve communications challenges.
The Core, briefly mentioned above, defines the resource types, prop-
erties and operations to be supported by all OSLC service providers
including Change Management (OSLC CM) providers.
Examples of possible OSLC CM Resources include defect, en-
hancement, task, bug, activity, and any application lifecycle manage-
ment or product lifecycle management artifacts. Resource types are
defined by the properties that are allowed and required in the resource.
The properties defined in the OSLC Change Management Specifica-
tion describe these resource types and the relationships between them
and all other resources. The relationship properties describe in most
general terms for example that
 the change request affects a plan item
 the change request is affected by a reported defect
 the change request tracks the associated Requirement
 the change request implements associated Requirement
 the change request affects a Requirement
OSLC is currently at the technology trigger stage along its hype cycle
[30]. It is already clear however that it is the approach which has the
potential to have a determining impact on the future of the satisfaction
of the traceability requirements.
Full traceability of a requirement throughout the development chain
and even the entire supply chain was also a major focus point of the
European CESAR project (Cost-Eﬃcient Methods and Processes for
Safety Relevant Embedded Systems) which adopted interoperability
technologies proposed by the OSLC initiative.
Another important European project, completed in 2013 and exploiting
OSLC, is iFEST (industrial Framework for Embedded Systems Tools).
CRYSTAL (CRitical sYSTem engineering AcceLeration) is a currently
running ARTEMIS Innovation Pilot Project (AIPP) whose Interopera-
bility Specification (IOS) is also based on OSLC.
8 Conclusion
In order to improve their implementation of traceability an organisa-
tion needs to be able to identify gaps in their existing traceability pro-
cess. Hence this paper presents the development and validation of a
traceability PAM. This PAM is based on the ISO 15504 structure and
used the TIPA transformation process for development. Validation of
the model, first through expert review and then by trial in two medical
device organisations, verifies that the model can identify both strengths
and weaknesses in an organisations existing traceability processes. It
can also be used to assess the state of a suppliers traceability process.
If our envisioned system, based on the processes defined in the
Traceability Process Assessment Model of this paper, could seamlessly
access the resources and their relationships using OSLC across all tools
applied in the entire software development lifecycle (SDLC), then
traceability process assessment and maintenance could be fully auto-
mated.
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